BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 28806363)

  • 1. Clinical Epidemiology of Single Versus Multiple Substance Use Disorders: Polysubstance Use Disorder.
    Bhalla IP; Stefanovics EA; Rosenheck RA
    Med Care; 2017 Sep; 55 Suppl 9 Suppl 2():S24-S32. PubMed ID: 28806363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTSD and substance use disorder among veterans: characteristics, service utilization and pharmacotherapy.
    Bowe A; Rosenheck R
    J Dual Diagn; 2015; 11(1):22-32. PubMed ID: 25513763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High inpatient utilization among Veterans Health Administration patients with substance-use disorders and co-occurring mental health conditions.
    Painter JM; Malte CA; Rubinsky AD; Campellone TR; Gilmore AK; Baer JS; Hawkins EJ
    Am J Drug Alcohol Abuse; 2018; 44(3):386-394. PubMed ID: 29095057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substance Use Disorder Among Current Cancer Patients: Rates and Correlates Nationally in the Department of Veterans Affairs.
    Ho P; Rosenheck R
    Psychosomatics; 2018; 59(3):267-276. PubMed ID: 29452704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration.
    Lin LA; Bohnert ASB; Blow FC; Gordon AJ; Ignacio RV; Kim HM; Ilgen MA
    Addiction; 2021 Jan; 116(1):96-104. PubMed ID: 32428386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychiatric services and prescription fills among veterans with serious mental illness in methadone maintenance treatment.
    Marienfeld C; Rosenheck RA
    J Dual Diagn; 2015; 11(2):128-35. PubMed ID: 25781867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The associations between substance use disorders, schizophrenia-spectrum disorders, and Axis IV psychosocial problems.
    Compton MT; Weiss PS; West JC; Kaslow NJ
    Soc Psychiatry Psychiatr Epidemiol; 2005 Dec; 40(12):939-46. PubMed ID: 16247563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of mental illness and substance use disorders with prescription contraception use among women veterans.
    Callegari LS; Zhao X; Nelson KM; Lehavot K; Bradley KA; Borrero S
    Contraception; 2014 Jul; 90(1):97-103. PubMed ID: 24731860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substance use disorders and the risk of suicide mortality among men and women in the US Veterans Health Administration.
    Bohnert KM; Ilgen MA; Louzon S; McCarthy JF; Katz IR
    Addiction; 2017 Jul; 112(7):1193-1201. PubMed ID: 28301070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender differences in veterans health administration mental health service use: effects of age and psychiatric diagnosis.
    Chatterjee S; Rath ME; Spiro A; Eisen S; Sloan KL; Rosen AK
    Womens Health Issues; 2009; 19(3):176-84. PubMed ID: 19447322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substance Use Relapse Among Veterans at Termination of Treatment for Substance Use Disorders.
    Betancourt CA; Kitsantas P; Goldberg DG; Hawks BA
    Mil Med; 2022 Oct; 187(11-12):e1422-e1431. PubMed ID: 34272857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contraceptive adherence among women Veterans with mental illness and substance use disorder.
    Callegari LS; Zhao X; Nelson KM; Borrero S
    Contraception; 2015 May; 91(5):386-92. PubMed ID: 25636807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health care cost trajectories in the year prior to and following intake into Veterans Health Administration outpatient substance use disorders treatment.
    Hagedorn HJ; Noorbaloochi S; Bangerter A; Stitzer ML; Kivlahan D
    J Subst Abuse Treat; 2017 Aug; 79():46-52. PubMed ID: 28673526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple Psychiatric Morbidity and Continued Use of Naltrexone for Alcohol Use Disorder.
    Muvvala SB; O'Malley SS; Rosenheck R
    Am J Addict; 2021 Jan; 30(1):55-64. PubMed ID: 32805083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Veterans Affairs Health System and mental health treatment retention among patients with serious mental illness: evaluating accessibility and availability barriers.
    McCarthy JF; Blow FC; Valenstein M; Fischer EP; Owen RR; Barry KL; Hudson TJ; Ignacio RV
    Health Serv Res; 2007 Jun; 42(3 Pt 1):1042-60. PubMed ID: 17489903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cost of treating substance abuse patients with and without comorbid psychiatric disorders.
    Hoff RA; Rosenheck RA
    Psychiatr Serv; 1999 Oct; 50(10):1309-15. PubMed ID: 10506299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substance Use Disorder Treatment Services for Women in the Veterans Health Administration.
    Timko C; Hoggatt KJ; Wu FM; Tjemsland A; Cucciare M; Rubin A; Simpson TL
    Womens Health Issues; 2017; 27(6):639-645. PubMed ID: 28602581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tobacco dependence diagnosis and treatment in Veterans Health Administration residential substance use disorder treatment programs.
    Gifford EV; Tavakoli S; Wang R; Hagedorn HJ; Hamlett-Berry KW
    Addiction; 2013 Jun; 108(6):1127-35. PubMed ID: 23297756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender Differences in the Prevalence of Fibromyalgia and in Concomitant Medical and Psychiatric Disorders: A National Veterans Health Administration Study.
    Arout CA; Sofuoglu M; Bastian LA; Rosenheck RA
    J Womens Health (Larchmt); 2018 Aug; 27(8):1035-1044. PubMed ID: 29608126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlates of major depressive disorder with and without comorbid alcohol use disorder nationally in the veterans health administration.
    Yoon G; Petrakis IL; Rosenheck RA
    Am J Addict; 2015 Aug; 24(5):419-26. PubMed ID: 25950244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.